Skip to main content

Table 2 Incidence rates and hazard ratios for various lung diseases in individuals with incident systemic lupus erythematosus and general population comparators (2003–2013)

From: New-onset non-infectious pulmonary manifestations among patients with systemic lupus erythematosus in Sweden

 

Incident SLE (n = 3209)

General population (n = 17,658)

 

Cases, n (%)

Person-years

Incidence rate per

1000 person-years (95% CI)

Cases,

n (%)

Person-years

Incidence rate per

1000 person-years (95% CI)

Adjusted hazard ratio (95% CI)a

Any pulmonary disease

227 (7.1)

15,208

14.9 (13.1–17.0)

246 (1.4)

90,374

2.7 (2.4–3.1)

5.8 (4.8–7.0)

By specific pulmonary disease

 Interstitial lung disease

48 (1.5)

15,535

3.1 (2.3–4.1)

15 (0.1)

90,738

0.2 (0.1–0.3)

19.0 (10.7–34.0)

 ARDS and hemorrhage

16 (0.5)

15,672

1.0 (0.6–1.7)

18 (0.1)

90,704

0.2 (0.1–0.3)

5.3 (2.7–10.5)

 Pleural disorders

91 (2.8)

15,400

5.9 (4.8–7.3)

93 (0.5)

90,576

1.0 (0.8–1.3)

5.9 (4.4–7.9)

 Pulmonary hypertension

18 (0.6)

15,675

1.2 (0.7–1.8)

18 (0.1)

90,737

0.2 (0.1–0.3)

6.1 (3.2–11.8)

 Pulmonary embolism

49 (1.5)

15,568

3.2 (2.4–4.2)

78 (0.4)

90,595

0.9 (0.7–1.1)

3.8 (2.6–5.4)

 Diseases of the upper airway

15 (0.5)

15,655

1.0 (0.6–1.6)

29 (0.2)

90,685

0.3 (0.2–0.5)

3.1 (1.7–5.8)

 Pulmonary edema

8 (0.3)

15,703

0.5 (0.3–1.0)

15 (0.1)

90,752

0.2 (0.1–0.3)

3.3 (1.4–7.8)

  1. SLE systemic lupus erythematosus, CI confidence interval
  2. aModel adjusted for age (continuous) and sex